ArticleGene therapy2015

Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-concept.

C Leboeuf et al.PubMed ↗Publisher ↗

No numbers read from the abstract.